A citation-based method for searching scientific literature

Nikita Wright, Padmashree C G Rida, Ritu Aneja. Front Biosci (Landmark Ed) 2017
Times Cited: 9







List of co-cited articles
52 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
44

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
44

Breast cancer molecular subtypes: from TNBC to QNBC.
Jane Date C Hon, Baljit Singh, Aysegul Sahin, Gang Du, Jinhua Wang, Vincent Y Wang, Fang-Ming Deng, David Y Zhang, Marie E Monaco, Peng Lee. Am J Cancer Res 2016
96
33

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Tiffany A Traina, Kathy Miller, Denise A Yardley, Janice Eakle, Lee S Schwartzberg, Joyce O'Shaughnessy, William Gradishar, Peter Schmid, Eric Winer, Catherine Kelly,[...]. J Clin Oncol 2018
235
33

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.
Ayca Gucalp, Sara Tolaney, Steven J Isakoff, James N Ingle, Minetta C Liu, Lisa A Carey, Kimberly Blackwell, Hope Rugo, Lisle Nabell, Andres Forero,[...]. Clin Cancer Res 2013
431
33

Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
Francisco E Vera-Badillo, Arnoud J Templeton, Paulo de Gouveia, Ivan Diaz-Padilla, Philippe L Bedard, Mustafa Al-Mubarak, Bostjan Seruga, Ian F Tannock, Alberto Ocana, Eitan Amir. J Natl Cancer Inst 2014
218
33

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.
Shristi Bhattarai, Sergey Klimov, Karuna Mittal, Uma Krishnamurti, Xiaoxian Bill Li, Gabriela Oprea-Ilies, Ceyda Sonmez Wetherilt, Ansa Riaz, Mohammed A Aleskandarany, Andrew R Green,[...]. Cancers (Basel) 2019
35
33

Expression of androgen receptors in primary breast cancer.
S Park, J Koo, H S Park, J-H Kim, S-Y Choi, J H Lee, B-W Park, K S Lee. Ann Oncol 2010
244
33

Prognostic markers in triple-negative breast cancer.
Emad A Rakha, Maysa E El-Sayed, Andrew R Green, Andrew H S Lee, John F Robertson, Ian O Ellis. Cancer 2007
912
33


Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.
Jiehua He, Roujun Peng, Zhongyu Yuan, Shusen Wang, Jiewen Peng, Guinan Lin, Xiaomei Jiang, Tao Qin. Med Oncol 2012
114
33

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
33

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer.
Yuka Asano, Shinichiro Kashiwagi, Wataru Goto, Sayaka Tanaka, Tamami Morisaki, Tsutomu Takashima, Satoru Noda, Naoyoshi Onoda, Masahiko Ohsawa, Kosei Hirakawa,[...]. Cancers (Basel) 2017
39
33

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Dawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, Diana M Cittelly, Erin N Howe, Nicholas C D'Amato, Nicole S Spoelstra, Susan M Edgerton, Annie Jean, Javier Guerrero,[...]. Breast Cancer Res 2014
256
33

Expression and clinical significance of androgen receptor in triple negative breast cancer.
Xiang Luo, Yan-Xia Shi, Zhi-Ming Li, Wen-Qi Jiang. Chin J Cancer 2010
81
33

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.
Giampaolo Bianchini, Justin M Balko, Ingrid A Mayer, Melinda E Sanders, Luca Gianni. Nat Rev Clin Oncol 2016
33

Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells.
Francesco Caiazza, Alyson Murray, Stephen F Madden, Naoise C Synnott, Elizabeth J Ryan, Norma O'Donovan, John Crown, Michael J Duffy. Endocr Relat Cancer 2016
36
33

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
33



The causes and consequences of genetic heterogeneity in cancer evolution.
Rebecca A Burrell, Nicholas McGranahan, Jiri Bartek, Charles Swanton. Nature 2013
22

Genomic instability--an evolving hallmark of cancer.
Simona Negrini, Vassilis G Gorgoulis, Thanos D Halazonetis. Nat Rev Mol Cell Biol 2010
22

Tumour heterogeneity and cancer cell plasticity.
Corbin E Meacham, Sean J Morrison. Nature 2013
22

Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk, Vanessa Almendro, Kornelia Polyak. Nat Rev Cancer 2012
22




Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Amelia A Peters, Grant Buchanan, Carmela Ricciardelli, Tina Bianco-Miotto, Margaret M Centenera, Jonathan M Harris, Shalini Jindal, Davendra Segara, Li Jia, Nicole L Moore,[...]. Cancer Res 2009
274
22

KIFC1 is a novel potential therapeutic target for breast cancer.
Yonghe Li, Wenyan Lu, Dongquan Chen, Rebecca J Boohaker, Ling Zhai, Indira Padmalayam, Krister Wennerberg, Bo Xu, Wei Zhang. Cancer Biol Ther 2015
55
22

Approach to the Triple Negative Breast Cancer in New Drugs Area.
Mehrzad Mirzania. Int J Hematol Oncol Stem Cell Res 2016
17
22

AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
Melissa Davis, Shweta Tripathi, Raymond Hughley, Qinghua He, Sejong Bae, Balasubramanyam Karanam, Rachel Martini, Lisa Newman, Windy Colomb, William Grizzle,[...]. PLoS One 2018
30
22

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
Yong Yue, Kristine Astvatsaturyan, Xiaojiang Cui, Xiao Zhang, Benedick Fraass, Shikha Bose. PLoS One 2016
18
22

Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
Xinyu Wu, Yirong Li, Jinhua Wang, Xin Wen, Max T Marcus, Garrett Daniels, David Y Zhang, Fei Ye, Ling Hang Wang, Xinxin Du,[...]. PLoS One 2013
58
22

The role of androgens in mammary carcinogenesis.
Y C Wong, B Xie. Ital J Anat Embryol 2001
25
22

Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
T E Hickey, J L L Robinson, J S Carroll, W D Tilley. Mol Endocrinol 2012
196
22

Measures of outcome in metastatic breast cancer: insights from a real-world scenario.
Marta Bonotto, Lorenzo Gerratana, Elena Poletto, Pamela Driol, Manuela Giangreco, Stefania Russo, Alessandro M Minisini, Claudia Andreetta, Mauro Mansutti, Federica E Pisa,[...]. Oncologist 2014
143
22



Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer.
Aye Aye Thike, Luke Yong-Zheng Chong, Poh Yian Cheok, Hui Hua Li, George Wai-Cheong Yip, Boon Huat Bay, Gary Man-Kit Tse, Jabed Iqbal, Puay Hoon Tan. Mod Pathol 2014
105
22

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Valerie N Barton, Nicholas C D'Amato, Michael A Gordon, Jessica L Christenson, Anthony Elias, Jennifer K Richer. Horm Cancer 2015
67
22

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.
Hiroko Masuda, Keith A Baggerly, Ying Wang, Ya Zhang, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Vicente Valero, Brian D Lehmann, Jennifer A Pietenpol, Gabriel N Hortobagyi,[...]. Clin Cancer Res 2013
449
22

Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1.
Jiaquan Wu, Keith Mikule, Wenxian Wang, Nancy Su, Philip Petteruti, Farzin Gharahdaghi, Erin Code, Xiahui Zhu, Kelly Jacques, Zhongwu Lai,[...]. ACS Chem Biol 2013
65
22

Expression of androgen receptor in breast cancer and its significance as a prognostic factor.
Q Yu, Y Niu, N Liu, J Z Zhang, T J Liu, R J Zhang, S L Wang, X M Ding, X Q Xiao. Ann Oncol 2011
85
22

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.
Matthew D Burstein, Anna Tsimelzon, Graham M Poage, Kyle R Covington, Alejandro Contreras, Suzanne A W Fuqua, Michelle I Savage, C Kent Osborne, Susan G Hilsenbeck, Jenny C Chang,[...]. Clin Cancer Res 2015
691
22

Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.
Pierluigi Gasparini, Matteo Fassan, Luciano Cascione, Gulnur Guler, Serdar Balci, Cigdem Irkkan, Carolyn Paisie, Francesca Lovat, Carl Morrison, Jianying Zhang,[...]. PLoS One 2014
60
22

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
Brian D Lehmann, Bojana Jovanović, Xi Chen, Monica V Estrada, Kimberly N Johnson, Yu Shyr, Harold L Moses, Melinda E Sanders, Jennifer A Pietenpol. PLoS One 2016
611
22

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer.
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, Erica L Mayer, Tufia C Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R Nangia, Paula I Gonzalez-Ericsson,[...]. Clin Cancer Res 2020
55
22

Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
Lisa M Sutton, Dengfeng Cao, Venetia Sarode, Kyle H Molberg, Kwame Torgbe, Barbara Haley, Yan Peng. Am J Clin Pathol 2012
60
22

Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer.
Jung Eun Choi, Su Hwan Kang, Soo Jung Lee, Young Kyung Bae. Ann Surg Oncol 2015
88
22

Triple-negative breast cancer: role of the androgen receptor.
Ayca Gucalp, Tiffany A Traina. Cancer J 2010
96
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.